Denali Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $1.15B
Liabilities Breakdown FY2023
Total Liabilities: $123.0M
Asset Breakdown
Total Assets: $1.15B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $127.1M | 11.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $45.6M | 4.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $981.2M | 85.0% |
Liabilities Breakdown
Total Liabilities: $123.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.5M | 7.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $113.5M | 92.3% |